Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortison-POS versus Ficortril for acute allergic ocular surface/adnexal inflammation
ISRCTN15464650Phase 3Completed
- Sponsor
- URSAPHARM
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hydrocortisone in allergic conjunctivitis (AC) and allergic blepharitis (3 arms), sponsored by URSAPHARM. Primary endpoint: Time to first occurrence of at least 50% reduction in sum score of signs and symptoms. Started May 2009; status: completed.
02
Drugs
hydrocortisone
03
Conditions
allergic conjunctivitis (AC)allergic blepharitis
Beyond the preview
Go deeper on ISRCTN15464650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15464650.